Log in or Sign up for Free to view tailored content for your specialty!
Melanoma/Skin Cancer News
Patients with metastatic, locally advanced cutaneous SCC respond well to cemiplimab
Cemiplimab provided clinically meaningful responses for patients with metastatic and locally advanced cutaneous squamous cell carcinoma, according to a study.
Head and neck melanoma associated with more adverse prognostic features
Researchers confirmed that head and neck melanomas have distinct biological characteristics that make it more adverse to patients yet more responsive to immunotherapy, according to a study.
Long-term data support pembrolizumab as ‘a standard of care’ in advanced melanoma
Pembrolizumab significantly extended OS at 10 years compared with ipilimumab for patients with advanced melanoma, according to study results presented at ESMO Congress.
Log in or Sign up for Free to view tailored content for your specialty!
Nivolumab plus ipilimumab offers ‘potential for cure’ in advanced melanoma
The addition of nivolumab to ipilimumab conferred a long-term OS benefit for patients with advanced melanoma, according to study results presented at ESMO Congress.
‘Simple model’ helps identify melanoma recurrence
A “simple model” known as ATLAS can help physicians detect recurrent cutaneous melanoma through symptom review, according to researchers.
FDA approves first subcutaneous anti-PD-L1 cancer immunotherapy
The FDA approved atezolizumab and hyaluronidase-tqjs for subcutaneous injection.
Veterans experience higher rates of skin cancer, psoriasis than nonveterans
Veterans experience higher prevalence rates of skin cancer, especially melanoma, and psoriasis compared with nonveterans, according to a study.
DecisionDx-SCC test stratifies skin cancer metastatic risk, guides treatment
The DecisionDx-SCC test successfully identified which patients with cutaneous squamous cell carcinoma would most likely benefit from adjuvant radiation therapy, according to a study.
‘Clear as mud’: Why the FDA has not approved new sunscreen ingredients
The FDA has not approved a new sunscreen ingredient since the 1990s, leaving consumers and clinicians wondering why.
Medicus initiates phase 2 trial of D-MNA for basal cell carcinoma
The first patient has been enrolled in a phase 2 clinical trial of D-MNA for the treatment of basal cell carcinoma, Medicus Pharma announced in a press release.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read